Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $33.3150 (-0.39%) ($33.3150 - $33.3150) on Thu. May. 18, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.3% (three month average) | RSI | 56 | Latest Price | $33.3150(-0.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.1% a day on average for past five trading days. | Weekly Trend | HALO advances 2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(37%) IWO(37%) XBI(35%) IWM(34%) IBB(31%) | Factors Impacting HALO price | HALO will decline at least -1.65% in a week (0% probabilities). UUP(-16%) TBT(-11%) VXX(-9%) IPO(-3%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.65% (StdDev 3.3%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $33.4(-0.25%) | 10 Day Moving Average | $32.69(1.91%) | 20 Day Moving Average | $32.62(2.13%) | To recent high | -33.9% | To recent low | 10.5% | Market Cap | $4.553b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |